TRNS TRANSCAT INC
Instruments For Meas & Testing of Electricity & Elec Signals · Nasdaq · SEC CIK 99302 · Fiscal year ends 03/27
Financial factors as of 2026-03-28 (FY2026), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY19.2%
TTM net income YoY-63.0%
TTM EPS YoY-63.7%
Revenue 3-yr CAGR12.9%
Net income 3-yr CAGR-20.5%
Margins
Gross margin32.6%
Operating margin4.0%
Net margin1.6%
FCF margin5.9%
EBITDA margin11.9%
Returns
ROE1.8%
ROA1.2%
ROIC (approx.)2.5%
Asset turnover0.77x
Leverage & solvency
Liabilities / assets37.4%
Debt / equity0.33x
Current ratio2.33x
Interest coverage2.88x
Cash quality & payout
Operating cash flow / net income6.48x
Accruals ratio-6.8%
Payout ratio—
Capex / revenue4.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-28 | FY20252025-03-29 |
|---|---|---|
| Income statement | ||
| Revenue | $331.88M | $278.42M |
| Cost of revenue | $223.57M | $188.97M |
| Gross profit | $108.30M | $89.45M |
| SG&A expense | $52.28M | $38.24M |
| Operating income | $13.26M | $17.87M |
| Interest expense | $4.60M | $798,000 |
| Pretax income | $7.99M | $18.33M |
| Income tax | $2.61M | $3.81M |
| Net income | $5.38M | $14.52M |
| EBITDA | $39.44M | $36.44M |
| EPS (basic) | 0.58 | 1.58 |
| EPS (diluted) | 0.57 | 1.57 |
| Weighted avg. shares (diluted) | 9.38M | 9.25M |
| Balance sheet | ||
| Cash & equivalents | $4.94M | $1.52M |
| Short-term investments | — | $0 |
| Receivables | $65.17M | $55.94M |
| Inventory | $13.71M | $14.48M |
| Current assets | $92.46M | $78.01M |
| PP&E, net | $57.80M | $50.02M |
| Goodwill | $218.19M | $176.93M |
| Intangibles | $77.71M | $54.78M |
| Total assets | $480.49M | $385.24M |
| Current liabilities | $39.63M | $34.04M |
| Short-term debt | $0 | $1.82M |
| Long-term debt | $99.89M | $30.89M |
| Total debt | $99.89M | $32.71M |
| Total liabilities | $179.87M | $98.36M |
| Shareholders' equity | $300.62M | $286.88M |
| Net debt | $94.94M | $31.19M |
| Shares outstanding | 9.33M | 9.32M |
| Cash flow statement | ||
| Operating cash flow | $34.85M | $38.98M |
| Capital expenditure | $15.30M | $13.20M |
| Free cash flow | $19.55M | $25.79M |
| Investing cash flow | -$97.82M | -$84.00M |
| Financing cash flow | $66.50M | $26.86M |
| Depreciation & amortization | $26.17M | $18.57M |
| Stock-based compensation | $7.55M | $3.25M |
| Share buybacks | $469,000 | $3.56M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.